Introduction
Complex polyketides are natural products, found predominantly in Strepto~nyces and related filamentous bacteria, that exhibit an impressive range of antibiotic, anticancer, anti-parasite and immunosuppressant activities. They are synthesized by a common pathway, in which units derived from acetate, propionate and (occasionally) butyrate are condensed onto the growing chain, in a process resembling fatty acid biosynthesis [1, 2] . The intermediates remain bound to the polyketide synthase (PKS) during multiple cycles of chain extension and (to a variable extent) reduction of the P-keto group formed in each condensation. The structural variation between naturally occurring polyketides arises largely from the way each PKS controls the number and type of units added, and the extent and stereochemistry of reduction at each cycle. In addition, the product of the PKS is frequently acted upon by regiospecific glycosylases, methyltransferases and oxidative enzymes, to produce still greater diversity.
Complex reduced polyketides such as the macrolides and polyethers are synthesized in bacteria on multifunctional PKSs that contain a separate set, or module, of enzymatic activities for every round of chain extension [3-7). For example, the clinically-important antibiotic erythromycin A is derived from propionyl-Cob and six molecules of (ZS)-methylmalonyl-CoA
[S], through the sequential action of six such sets of enzymes housed in the three multienzyme polypeptides [9] of 6-deoxyerythronolide B synthase (DEBS) (Fig. 1) . The most remarkable example so far studied is the PKS for the immunosuppressant rapamycin from Streptomyces hygroscop&s, which contains 14 modules housed in only 3 huge multienzyme polypeptides [lo] . In contrast to the modular type I PKS multienzymes, bacterial aromatic polyketides are synthesized by type II PKSs, comprising a single set of enzymes housed in separate proteins [l l-141. Considerable interest has developed in the possibility of generating hybrid polyketides by suitable combination of activities from different natural polyketide synthases. In pioneering experiments, Strohl and colleagues [15, 16] showed that when portions of the act biosynthetic gene cluster of Sfrept0myce.s coeLicoLor, encoding the type II PKS, were introduced into anthracycline-producing strains of Streptomyces gaMeus, novel polyketide metabolites were produced, whose structures demonstrated that productive hybrid type II PKSs were indeed formed. A large number of such experiments have since been systematically Chemistry & Biology 1996, Vol3 [23, 24] . This approach has been successfully used to produce other chain lengths by truncation of DEBS [25] .
We chose to replace the acyltransferase (AT) domain within module 1 of DEBSl-TE, the domain responsible for incorporation of a methylmalonyl extender unit during the first cycle of polyketide chain extension (Fig. 1) . Such AT domains are present in every module and are believed to form part of the structural core of a modular PKS [26, 27] . They are highly homologous as judged from sequence comparisons ['28 ], but within this overall homology there are discernible sequence differences between those AT domains that recruit an acetate unit from malonyl-CoA and those AT domains that recruit a propionate unit from methylmalonyl-CoA ( Fig. 2) [29]. We report here the results of specific replacement of the entire propionate-specific AT1 domain in DEBSl-TE with its acetate-specific counterpart from module 2 of the rapamycin-producing PKS (Fig. l) , and characterization of the products of the resulting hybrid modular PKS.
Results and discussion
Construction of the gene encoding the hybrid triketide synthase TKScamll
The starting point for construction of the chimaeric gene was a pT7-7-based plasmid housing the entire open reading frame for the DEBSl-TE gene. There are only two &ZLI restriction sites within this gene, which flank the target DNA encoding the AT1 domain. The cloning strategy, as detailed in Materials and methods, was therefore to exchange the SLZLI fragment for a new fragment into which the desired changes to the AT domain had been introduced (Fig. 3) . In plasmid plMO5 the StzlI fragment consists of, first, a PCR-generated Stul-Ball fragment, which extends to just inside the amino-terminal end of AT1 and introduces a unique BaA site without affecting the amino acid sequence (Fig. 2); and second, a PCR-generated fragment flanked by Bafl and A~11 sites on one end and a StuI site at the other, and encoding the extreme carboxyl terminus of ATl. The DNA encoding the new AT domain derived from rapamycin module 2 is excised from plasmid pMOZ and ligated into pM0.5 as a B&I-AvrII fragment, to produce plasmid pDl-AT,, encoding a full-length, heterologous AT domain (Fig. 3) . All PCR products were fully sequenced to check their integrity.
The vector used for expression of the hybrid gene in S. coelicalor was based on the useful bifunctional SCPZ"-based low copy number S. co&color plasmid pRM5, developed by Khosla, Hopwood and colleagues [17] , in which genes are placed under the control of the a& promoter. The modified plasmid contains unique A&I and XbaI sites downstream of the uct( promoter, into which the altered PKS gene, encoding the hybrid PKS (TKScamll) was conveniently cloned as an NdeI-XhaI fragment (Fig.  3) . The resulting expression plasmid pRM-AT2 was transformed into S. coelicolor CH999, a strain lacking the actinorhodin biosynthetic genes [ 171.
Polyketide production in vivo by the hybrid polyketide synthase TKScamll Previously, an engineered strain of S. coelicolor containing the DEBSl-TE multienzyme has been shown to produce a mixture of triketide lactones IA and 1B (Fig. l) 1A being the major product [23] . For reasons that remain broth of S. coelicolor expressing the hybrid multienzyme unclear, DEBSl alone, when overproduced using the TKScamll showed the complete absence of peaks identical system in S. coelicolor, is reported by others to corresponding either to 1A or 1B. In their place, two new produce 1B only [30] . In the present study, gas chromapeaks were observed (Fig. 4) which on further analysis tography (CC) analysis of extracts from the fermentation were shown to correspond to the novel lactones 2A and 2B (Fig. l) , formed in roughly equal amount, and arising from the use of, respectively, acetate or propionate as a starter unit for the PKS [31, 32] . The identity of the purified novel lactones was fully established by high resolution electrospray mass spectrometry, and by 'H and 13C NMR. The clear conclusion from these data is that the domain swap has successfully (and completely) altered the nature of the extension unit recruited by AT1 of the synthase, from a propionate to an acetate unit. There is no evidence, under the conditions used, for the formation of other diastereoisomers of 2A and 2B, so it appears that other events on the synthase catalyzed by module 1, particularly the reduction of the B-ketoacyl group, are not influenced by the engineered change. Similarly, module 2 has correctly processed the altered chain. The total yield of triketide lactone is also not greatly altered compared to that from DEBSl-TE in S. coelicolor under the same conditions [23] .
As indicated in Figure 1 , the normal context of the AT domain of module 2 is within the four-module multienzyme subunit RAPS1 of the rapamycin-producing polyketide synthase [10, 28] . Module 2 of RAPS1 accomplishes the incorporation of an acetate unit and its reduction to a hydroxyacyl thioester, and this made it a reasonable choice to replace the AT1 of DEBSl-TE, which incorporates a propionate unit and likewise reduces it to a hydroxyacyl thioester. The success of this domain swap does not allow us to claim that any AT domain can be replaced by any other, since other pairs of AT domains may have a normal context which is less favourably matched. However, given the relatively high degree of sequence identity between AT domains from different modular PKSs, this result does hold out the promise that any complex polyketide in which propionate units occur might be engineered in an analogous fashion, to create a derivative specifically lacking one or more branching methyl groups. If this approach can indeed be generalized, it will conveniently make available derivatives of known antibiotics that would be hard to obtain by chemical synthesis. If the approach of domain swapping can also be extended to the other constituent domains of the PKS, such as the ketosynthases and ketoreductases, then the number of novel modified polyketides brought within reach would be very large indeed.
Significance
The (Fig. 3) . Plasmid pM02 was digested with
Ball and Avrll and the insert was ligated into plasmid pM05 which had been cut with the same two enzymes to produce plasmid pDl-AT, (Fig. 3) . The hybrid PKS gene was excised from pD1 -AT, as an Ndel-Xbal fragment and ligated into pRM52 which had been similarly cut with Ndel and Xbal, to produce the expression plasmid pRM-AT2 (Fig. 3) .
Purification of (2S,3R,5R)-2-methyl-3,5-dihydroxy-n-heptanoic acid S-lactone and (2S,3R,5R)-2-methyl-3,5-dihydroxy-nhexanoic acid Hactone S. coelicolor was grown in 3 x 500 ml YEME medium (without sucrose) for 5 days in the presence of thiostrepton (10 mg I-'). Characterization of (2S, 3R, 5R)-2-methyl-3,5-dihydroxy-nhexanoic acid S-la&one @A) 'H NMR (CDCI, , 400 MHz) 6H 4.36 (lH, dqd, J = 11.9, 6.6, 3.1 Hz, 3.75 (1 H, ddd, J = 11.3, 9.9, 3.7 Hz, H-3), 2.32 (1 H, dq, J = 9.9, 6.8 Hz, H-2), 2.20 (lH, ddd, J = 13.3, 3.7, 3.1 Hz, , ), 1.65 (lH, ddd, J = 13.3, 11.9, 11.3 Hz, , ) ppm. 13C NMR (CDCI,, 100 MHz) 6C 173.3 (C-l), 77.7 (C-5), 70.4 (C-3), 45.1 (C-2), 37.7 (C-4), 28.8 (C-6), 13.5 (C-2'), 9. 
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